Takeda and ImmunoGen partner to develop and commercialise Elahere in Japan
ImmunoGen is expected to receive an upfront payment from Takeda plus additional payment
Read More
Tag: takeda
NICE recommends Takeda’s Ninlaro triplet regimen
Therapy involves patients living with relapsed or refractory multiple myeloma
Read More
Takeda findings may minimise haemophilia treatment side effects
Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help treat patients
Read More
Takeda’s dengue vaccine candidate delivers continued protection
Vital dengue vaccine offers over four years’ protection following successful clinical trial
Read More
Engetix and Takeda announce expanded collaboration for anti-fibrotic therapies
Engitix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
Read More
NHS fast-tracks new targeted drug for rare lung cancer
Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery
Read More
Takeda’s blood cancer drug fails to achieve Phase III endpoint
Pevonedistat plus azacitidine did not meet primary endpoint of EFS
Read More
Takeda takes the lead on Finch’s ulcerative colitis candidate FIN-524
The clinical development programme is now known as TAK-524
Read More
Takeda’s dengue vaccine bags positive long-term efficacy results
Vaccine candidate demonstrated 83.6% efficacy against hospitalisation three years after vaccination
Read More
Pandemic has made little positive impact on public’s view of pharma
A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry’s response to COVID-19
Read More
Crescendo Biologics expands Takeda collaboration
Follows previous agreements signed in November 2018 and July 2019
Read More
Takeda signs deal with UK biotech Engitix
The firms will use Engitix’ extracellular matrix (ECM) discovery platform to develop new therapies for fibrotic liver diseases
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
